151 related articles for article (PubMed ID: 7494186)
1. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs.
Sakane T; Akizuki M; Taki Y; Yamashita S; Sezaki H; Nadai T
J Pharm Pharmacol; 1995 May; 47(5):379-81. PubMed ID: 7494186
[TBL] [Abstract][Full Text] [Related]
2. Size-dependent dextran transport across rat alveolar epithelial cell monolayers.
Matsukawa Y; Lee VH; Crandall ED; Kim KJ
J Pharm Sci; 1997 Mar; 86(3):305-9. PubMed ID: 9050797
[TBL] [Abstract][Full Text] [Related]
3. Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats.
Dong Z; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2010 Jun; 393(1-2):244-52. PubMed ID: 20417700
[TBL] [Abstract][Full Text] [Related]
4. Effect of poly-L-arginine on the nasal absorption of FITC-dextran of different molecular weights and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats.
Miyamoto M; Natsume H; Satoh I; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 2001 Sep; 226(1-2):127-38. PubMed ID: 11532576
[TBL] [Abstract][Full Text] [Related]
5. Molecular weight dependence of permselectivity to rat small intestinal blood-lymph barrier for exogenous macromolecules absorbed from lumen.
Yoshikawa H; Takada K; Muranishi S
J Pharmacobiodyn; 1984 Jan; 7(1):1-6. PubMed ID: 6202865
[TBL] [Abstract][Full Text] [Related]
6. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug.
Sakane T; Akizuki M; Yamashita S; Sezaki H; Nadai T
J Pharm Pharmacol; 1994 May; 46(5):378-9. PubMed ID: 8083811
[TBL] [Abstract][Full Text] [Related]
7. Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity.
Sakane T; Akizuki M; Yoshida M; Yamashita S; Nadai T; Hashida M; Sezaki H
J Pharm Pharmacol; 1991 Jun; 43(6):449-51. PubMed ID: 1681064
[TBL] [Abstract][Full Text] [Related]
8. The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug.
Sakane T; Akizuki M; Yamashita S; Nadai T; Hashida M; Sezaki H
Chem Pharm Bull (Tokyo); 1991 Sep; 39(9):2456-8. PubMed ID: 1804561
[TBL] [Abstract][Full Text] [Related]
9. Uptake of fluorescein isothiocyanate-labelled dextran into the CSF after intranasal and intravenous administration to rats.
in 't Veen JP; van den Berg MP; Romeijn SG; Verhoef JC; Merkus FW
Eur J Pharm Biopharm; 2005 Sep; 61(1-2):27-31. PubMed ID: 15893918
[TBL] [Abstract][Full Text] [Related]
10. Influence of formulation viscosity on drug absorption following nasal application in rats.
Furubayashi T; Inoue D; Kamaguchi A; Higashi Y; Sakane T
Drug Metab Pharmacokinet; 2007 Jun; 22(3):206-11. PubMed ID: 17603222
[TBL] [Abstract][Full Text] [Related]
11. Absorption characteristics of model compounds with different molecular weights from the serosal caecal surface in rats.
Nishida K; Nose S; Kuma A; Mukai T; Kawakami S; Nakashima M; Sasaki H; Sakaeda T; Nakamura J
J Pharm Pharmacol; 2002 Jul; 54(7):1005-9. PubMed ID: 12162704
[TBL] [Abstract][Full Text] [Related]
12. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers.
Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW
Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535
[TBL] [Abstract][Full Text] [Related]
13. Analysis of transient and reversible effects of poly-L-arginine on the in vivo nasal absorption of FITC-dextran in rats.
Ohtake K; Natsume H; Ueda H; Morimoto Y
J Control Release; 2002 Aug; 82(2-3):263-75. PubMed ID: 12175742
[TBL] [Abstract][Full Text] [Related]
14. Transnasal delivery of 5-fluorouracil to the brain in the rat.
Sakane T; Yamashita S; Yata N; Sezaki H
J Drug Target; 1999; 7(3):233-40. PubMed ID: 10680979
[TBL] [Abstract][Full Text] [Related]
15. Improved nasal absorption of drugs using poly-L-arginine: effects of concentration and molecular weight of poly-L-arginine on the nasal absorption of fluorescein isothiocyanate-dextran in rats.
Miyamoto M; Natsume H; Iwata S; Ohtake K; Yamaguchi M; Kobayashi D; Sugibayashi K; Yamashina M; Morimoto Y
Eur J Pharm Biopharm; 2001 Jul; 52(1):21-30. PubMed ID: 11438420
[TBL] [Abstract][Full Text] [Related]
16. Screening of cationic compounds as an absorption enhancer for nasal drug delivery.
Natsume H; Iwata S; Ohtake K; Miyamoto M; Yamaguchi M; Hosoya K; Kobayashi D; Sugibayashi K; Morimoto Y
Int J Pharm; 1999 Aug; 185(1):1-12. PubMed ID: 10425360
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of brain-targeting for the nasal delivery of estradiol by the microdialysis method.
Wang X; He H; Leng W; Tang X
Int J Pharm; 2006 Jul; 317(1):40-6. PubMed ID: 16631329
[TBL] [Abstract][Full Text] [Related]
18. Molecular weight dependence on bioavailability of FITC-dextran after administration of self-dissolving micropile to rat skin.
Ito Y; Ise A; Sugioka N; Takada K
Drug Dev Ind Pharm; 2010 Jul; 36(7):845-51. PubMed ID: 20180657
[TBL] [Abstract][Full Text] [Related]
19. Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight.
Hosoya K; Kubo H; Akutsu T; Natsume H; Sugibayashi K; Morimoto Y
Arch Pharm Res; 1994 Apr; 17(2):57-9. PubMed ID: 10319131
[TBL] [Abstract][Full Text] [Related]
20. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine.
Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A
Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
